Psychedelic Bulletin: CB Therapeutics’ Biosynthesis Patent; MindMed to Explore Mescaline; BBC Documentary Highlights Psilocybin

Below, we discuss CB Therapeutics’ patent application that covers methods of biosynthetically producing psilocybin. We also touch on mescaline, which MindMed is set to investigate in a Phase 1 trial. In the Weekend Reading section, we share fMRI data from two psilocybin trials and highlight a recent BBC documentary titled The Psychedelic Drug Trial. CB Therapeutics’ Patent Application Met with…

Source